BioAffinity.jpg
bioAffinity Technologies Joins National Lung Cancer Roundtable
11 oct. 2019 11h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Oct. 11, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that it has been accepted as a member of the American Cancer...
BioAffinity.jpg
bioAffinity Technologies Announces Formation of Scientific and Medical Advisory Board; M. Patricia Rivera, MD, Joins Board as Chair
12 mars 2019 11h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, March 12, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced the formation of a Scientific and Medical Advisory (SMA) Board to provide...
BioAffinity.jpg
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
06 mars 2019 11h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) -- Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company developing diagnostics and therapeutics...
BioAffinity.jpg
bioAffinity Technologies Announces Award of Canadian Patent
04 févr. 2019 12h25 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, Feb. 04, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, announced that the Canadian Intellectual Property Office has awarded a patent expanding the...
BioAffinity.jpg
South Texas Veterans Health Care System Joins Test Validation Trial of bioAffinity’s CyPath® Lung
23 oct. 2018 11h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the South Texas Veterans Health Care System (STVHCS), which is...
BioAffinity.jpg
bioAffinity Licenses CyPath® Lung to Precision Pathology Services
10 oct. 2018 12h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced a licensing agreement with Precision Pathology Services for the continued...
BioAffinity.jpg
bioAffinity Technologies Welcomes Mohsin Y. Meghji to Board of Directors
31 juil. 2018 11h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, July 31, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Mohsin...
BioAffinity.jpg
bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung
17 juil. 2018 14h40 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an...
BioAffinity.jpg
bioAffinity Technologies Welcomes Peter S. Knight to Board of Directors
14 mai 2018 10h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, May 14, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biomedical company advancing breakthrough cancer diagnostics and therapeutics, is pleased to welcome Peter S....
BioAffinity.jpg
bioAffinity Technologies Joins Early Detection Research Network
01 mars 2018 11h00 HE | bioAffinity Technologies, Inc.
SAN ANTONIO, March 01, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has been approved for membership in the Early Detection...